Moreover, the significant correlation between body weight loss and increased serum ataxin-10 levels suggests that ataxin-10 could be considered to be a potential biomarker for diagnostic and or prognostic purposes in colon cancer [65]. Here, ATXN10 is linked to malignant colon neoplasm.